Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 12, 2008, Pages 1720-1725

  Wang, Lian Sheng ^a   Tang, Jian Jin ^a   Tang, Na Ping ^a,b   Wang, Min Wei ^a   Yan, Jian Jun ^a   Wang, Qi Min ^a   Yang, Zhi Jian ^a   Wang, Bin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b National Shanghai Center for New Drug Safety Evaluation and Research   (China)

Author keywords

Coronary artery disease; DNA damage; Glutathione S transferase gene polymorphisms; Smoking

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

CORONARY DISEASE; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

NICOTIANA TABACUM;

EID: 57449088194     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.353     Document Type: Article

References (30)

1. Cambien F, Tiret L. Genetics of cardiovascular diseases: from single mutations to the whole genome. Circulation 2007;116:1714-24.
2. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 2004;567:447-74.
3. Mirvish SS. Reducing carcinogen levels in cigarette smoke. Cancer Epidemiol Biomarkers Prev 2007;16:2170-1.
4. Knaapen AM, Curfs DM, Pachen DM, Gottschalk RW, de Winther MP, Daemen MJ, et al. The environmental carcinogen benzowaxpyrene induces expression of monocyte-chemoattractant protein-1 in vascular tissue: a possible role in atherogenesis. Mutat Res 2007;621:31-41.
5. Leone A. Smoking, haemostatic factors, and cardiovascular risk. Curr Pharm Des 2007;13:1661-7.
6. Kang JJ, Lee PJ, Chen YJ, Lee CC, Li CH, Cheng HW, et al. Naphthazarin and methylnaphthazarin cause vascular dysfunction by impairment of endothelium-derived nitric oxide and increased superoxide anion generation. Toxicol In Vitro 2006;20:43-51.
7. Khalil M, Abudiab M, Ahmed AE. Clinical evaluation of 1,3-butadiene neurotoxicity in humans. Toxicol Ind Health 2007;23:141-6.
8. Johnson CD, Balagurunathan Y, Lu KP, Tadesse M, Falahatpisheh MH, Carroll RJ, et al. Genomic profiles and predictive biological networks in oxidant-induced atherogenesis. Physiol Genomics 2003;13:263-75.
9. Izzotti A, Bagnasco M, Cartiglia C, Longobardi M, Camoirano A, Tampa E, et al. Modulation of multigene expression and proteome profiles by chemopreventive agents. Mutat Res 2005;591:212-23.
10. Ramos KS, Moorthy B. Bioactivation of polycyclic aromatic hydrocarbon carcinogens within the vascular wall: implications for human atherogenesis. Drug Metab Rev 2005;37:595-610.
11. Yang Z, Harrison CM, Chuang GC, Ballinger SW. The role of tobacco smoke induced mitochondrial damage in vascular dysfunction and atherosclerosis. Mutat Res 2007;621:61-74.
12. Wang XL, Raveendran M, Wang J. Genetic influence on cigarette-induced cardiovascular disease. Prog Cardiovasc Dis 2003;45:361-82.
13. Blanchette B, Feng X, Singh BR. Marine glutathione S-transferases. Mar Biotechnol (NY) 2007;9:513-42.
14. Xu S, Wang Y, Roe B, Pearson WR. Characterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletion. J Biol Chem 1998;273:3517-27.
15. Thier R, Brüning T, Roos PH, Rihs HP, Golka K, Ko Y, et al. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. Int J Hyg Environ Health 2003;206:149-71.
16. Li R, Boerwinkle E, Olshan AF, Chambless LE, Pankow JS, Tyroler HA, et al. Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease. Atherosclerosis 2000;149:451-62.
17. de Waart FG, Kok FJ, Smilde TJ, Hijmans A, Wollersheim H, Stalenhoef AF. Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers. Atherosclerosis 2001;158:227-31.
18. Wang XL, Greco M, Sim AS, Duarte N, Wang J, Wilcken DE. Glutathione S-transferase mu1 deficiency, cigarette smoking and coronary artery disease. J Cardiovasc Risk 2002;9:25-31.
19. Masetti S, Botto N, Manfredi S, Colombo MG, Rizza A, Vassalle C, et al. Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J Mol Med 2003;81:488-9.
20. Tamer L, Ercan B, Camsari A, Yildirim H, Cicek D, Sucu N, et al. Glutathione S-transferase gene polymorphism as a susceptibility factor in smoking-related coronary artery disease. Basic Res Cardiol 2004;99:223-9.
21. Wang B, Pan J, Wang L, Zhu H, Yu R, Zou Y. Associations of plasma 8-405 isoprostane levels with the presence and extent of coronary stenosis in 406 patients with coronary artery disease. Atherosclerosis 2006;184:425-30.
22. Abu-Amero KK, Al-Boudari OM, Mohamed GH, Dzimiri N. T null and M null genotypes of the glutathione S-transferase gene are risk factor for CAD independent of smoking. BMC Med Genet 2006;19:38.
23. Manfredi S, Federici C, Picano E, Botto N, Rizza A, Andreassi MG, et al. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study. Mutat Res 2007;621:106-12.
24. Wilson MH, Grant PJ, Hardie LJ, Wild CP. Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB J 2005;14:791-6.
25. Li R, Folsom AR, Sharrett AR, Couper D, Bray M, Tyroler HA. Glutathione S-transferase genes and cigarette smoking on risk of lower extremity arterial disease. Atherosclerosis 2000;154:729-38.
26. Girisha KM, Gilmour A, Mastana S, Singh VP, Sinha N, Tewari S, et al. T1 and M1 polymorphism in glutathione S-transferase gene and coronary artery disease in North Indian population. Indian J Med Sci 2004;58:520-6.
27. Binkova B, Chvatalova I, Lnenickova Z, Milcova A, Tulupova E, Farmer PB, et al. PAH-DNA adducts in environmentally exposed population in relation to metabolic and DNA repair gene polymorphisms. Mutat Res 2007;620:49-61.
28. Palma S, Cornetta T, Padua L, Cozzi R, Appolloni M, Ievoli E, et al. Influence of glutathione S-transferase polymorphisms on genotoxic effects induced by tobacco smoke. Mutat Res 2007;633:1-12.
29. Izzotti A, Cartiglia C, Lewtas J. Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype. FASEB J 2001;15:752-7.
30. Watkins H, Farrall M. Genetic susceptibility to coronary artery disease: from promise to progress. Nat Rev Genet 2006;7:163-73.